Number of the records: 1
Epigenetics in breast cancer therapy - new strategies and future nanomedicine perspectives
Title Epigenetics in breast cancer therapy - new strategies and future nanomedicine perspectives Author Buociková Verona SAVEXONK ; SAVBIOMED - Ústav experimentálnej onkológie SAV Co-authors Rios-Mondragon Ivan Pilalis Eleftherios Chatziioannou Aristotelis Miklíková Svetlana 1988- SAVEXONK ; SAVBIOMED - Ústav experimentálnej onkológie SAV SCOPUS ORCID Mego Michal Pajuste Karlis Rucins Martins Yamani Naouale El Longhin Eleonora Marta Sobolev Arkadij Freixanet M. Plotniece Aiva Dušinská Mária Cimpan M. R. Gábelová Alena 1955- SAVEXONK ; SAVBIOMED - Ústav experimentálnej onkológie SAV SCOPUS ORCID Smolková Božena 1968- SAVEXONK ; SAVBIOMED - Ústav experimentálnej onkológie SAV SCOPUS RID ORCID Source document Cancers. Vol. 12 (2020), art. no. 3622 Language eng - English Note open access Document kind rozpis článkov z periodík (rbx) Citations GIANNI, C. - PALLESCHI, M. - MERLONI, F. - DI MENNA, G. - SIRICO, M. - SARTI, S. - VIRGA, A. - ULIVI, P. - CECCONETTO, L. - MARIOTTI, M. - DE GIORGI, U. Cell-Free DNA Fragmentomics: A Promising Biomarker for Diagnosis, Prognosis and Prediction of Response in Breast Cancer. In INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. ISSN 1661-6596, NOV 2022, vol. 23, no. 22. Dostupné na: https://doi.org/10.3390/ijms232214197. SENGUPTA, P. - CHOUDHURY, H. - DUTTA, S. - JACOB, S. - KESHARWANI, P. - GORAIN, B. Current Strategies in Breast Cancer Therapy: Role of Epigenetics and Nanomedicine. In PARTICLE & PARTICLE SYSTEMS CHARACTERIZATION. ISSN 0934-0866, JUL 2022, vol. 39, no. 7. Dostupné na: https://doi.org/10.1002/ppsc.202100276. BALBUENA-REBOLLEDO, I. - RIVERA-ANTONIO, A.M. - SIXTO-LóPEZ, Y. - CORREA-BASURTO, J. - ROSALES-HERNáNDEZ, M.C. - MENDIETA-WEJEBE, J.E. - MARTíNEZ-MARTíNEZ, F.J. - OLIVARES-CORICHI, I.M. - GARCíA-SáNCHEZ, J.R. - GUEVARA-SALAZAR, J.A. - BELLO, M. - PADILLA-MARTíNEZ, I.I. Dihydropyrazole-Carbohydrazide Derivatives with Dual Activity as Antioxidant and Anti-Proliferative Drugs on Breast Cancer Targeting the HDAC6. In PHARMACEUTICALS. JUN 2022, vol. 15, no. 6. Dostupné na: https://doi.org/10.3390/ph15060690. ALEXANDROVA, E. - SALVATI, A. - PECORARO, G. - LAMBERTI, J. - MELONE, V. - SELLITTO, A. - RIZZO, F. - GIURATO, G. - TARALLO, R. - NASSA, G. - WEISZ, A. Histone Methyltransferase DOT1L as a Promising Epigenetic Target for Treatment of Solid Tumors. In FRONTIERS IN GENETICS. APR 13 2022, vol. 13. Dostupné na: https://doi.org/10.3389/fgene.2022.864612. TARHONSKA, K. - LESICKA, M. - JANASIK, B. - ROSZAK, J. - RESZKA, E. - BRAUN, M. - KOLACINSKA-WOW, A. - JABLONSKA, E. Cadmium and breast cancer-Current state and research gaps in the underlying mechanisms. In TOXICOLOGY LETTERS. ISSN 0378-4274, MAY 15 2022, vol. 361, p. 29-42. Dostupné na: https://doi.org/10.1016/j.toxlet.2022.03.003. CHEN, J.Y. - ZHUANG, Y.X. - WANG, P. - NING, J.F. - LIU, W. - HUANG, Y.T. - LIN, X.Q. - PENG, L. - ZHANG, D.H. Reducing N6AMT1-mediated 6mA DNA modification promotes breast tumor progression via transcriptional repressing cell cycle inhibitors. In CELL DEATH & DISEASE. ISSN 2041-4889, MAR 7 2022, vol. 13, no. 3. Dostupné na: https://doi.org/10.1038/s41419-022-04661-8. CELESNIK, H. - POTOCNIK, U. Peripheral Blood Transcriptome in Breast Cancer Patients as a Source of Less Invasive Immune Biomarkers for Personalized Medicine, and Implications for Triple Negative Breast Cancer. In CANCERS. FEB 2022, vol. 14, no. 3. Dostupné na: https://doi.org/10.3390/cancers14030591. Category ADMA - Scientific papers in foreign impacted journals registered in Web of Sciences or Scopus Category of document (from 2022) V3 - Vedecký výstup publikačnej činnosti z časopisu Type of document článok Year 2020 Registered in WOS Registered in SCOPUS DOI 10.3390/cancers12123622 article
File name Access Size Downloaded Type License Epigenetics in breast cancer therapy - new strategies and future nanomedicine perspectives.pdf available 1.3 MB 6 Publisher's version rok CC IF IF Q (best) JCR Av Jour IF Perc SJR SJR Q (best) CiteScore N rok vydania rok metriky IF IF Q (best) SJR SJR Q (best) 2020 2019 6.126 Q1 1.938 Q1
Number of the records: 1